October 28, 2010 - Coronary stent manufacturer Stentys is now listed and traded on the NYSE Euronext Paris ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbableย stents, and renal stents.ย
October 22, 2010 - Treating metabolic syndrome and undergoing carotid angioplasty may prevent recurrent stroke or ...
October 14, 2010 โ A bifurcation stent maker has closed $17 million in round D financing to help it expand ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
October 1, 2010 โ The Bradenton Cardiology Center is the first clinic in the United States to implant a peripheral ...
October 1, 2010 โ The maker of a biodegradable stent has brought in $8.5 million during a new round of venture ...
September 28, 2010 โ A new multinational trial will examine the effectiveness of embolic protection mesh stents in ...
September 28, 2010 โ Three-year follow-up data from the HORIZONS-AMI trial presented at Transcatheter ...
September 27, 2010 โ A post-market study investigating a new treatment for peripheral artery disease of the ...
September 27, 2010 โ A premarket approval (PMA) application has been submitted for the Formula balloon-expandable ...
September 24, 2010 โ Drug-eluting stents are beneficial in treating symptomatic peripheral artery disease (PAD) in ...
September 24, 2010 - Two-year data from the SPIRIT IV trial show that everolimus-eluting stents demonstrated ...
September 23, 2010 - Results from the second stage of a trial studying a bioresorbable vascular scaffold were ...
September 23, 2010 - Results from a study evaluating the safety and clinical efficacy of the Promus Element ...
September 22, 2010 โ Coronary artery disease, a leading cause of death and poor quality of life worldwide, can ...
September 22, 2010 โ Trial data indicate that a new stent may be a safer solution to treat heart attack patients ...